Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
|更新时间:2024-10-09
|
Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
“The latest research reveals that Xuefu Zhuyu Capsule can significantly improve dyslipidemia and aortic plaque in atherosclerotic mice by regulating Sirt3/EPAC1 signaling pathway, providing a new strategy for treating atherosclerosis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 21, Pages: 31-41(2024)
YAO Bo,CHEN Hengwen,GONG Jiyu,et al.Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):31-41.
YAO Bo,CHEN Hengwen,GONG Jiyu,et al.Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):31-41. DOI: 10.13422/j.cnki.syfjx.20241622.
Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway